Veritable’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,205
| Closed | -$2.54M | – | 798 |
|
|
2023
Q2 | $2.54M | Sell |
7,205
-130
| -2% | -$45.7K | 0.04% | 200 |
|
|
2023
Q1 | $2.31M | Buy |
7,335
+147
| +2% | +$46.3K | 0.04% | 206 |
|
|
2022
Q4 | $2.08M | Buy |
7,188
+197
| +3% | +$56.9K | 0.04% | 228 |
|
|
2022
Q3 | $2.02M | Buy |
6,991
+9
| +0.1% | +$2.61K | 0.04% | 218 |
|
|
2022
Q2 | $1.97M | Buy |
6,982
+384
| +6% | +$108K | 0.04% | 241 |
|
|
2022
Q1 | $1.72M | Buy |
6,598
+173
| +3% | +$45.2K | 0.03% | 285 |
|
|
2021
Q4 | $1.41M | Sell |
6,425
-317
| -5% | -$69.6K | 0.02% | 325 |
|
|
2021
Q3 | $1.22M | Sell |
6,742
-125
| -2% | -$22.7K | 0.02% | 333 |
|
|
2021
Q2 | $1.39M | Buy |
6,867
+51
| +0.7% | +$10.3K | 0.02% | 315 |
|
|
2021
Q1 | $1.47M | Buy |
6,816
+702
| +11% | +$151K | 0.02% | 282 |
|
|
2020
Q4 | $1.45M | Sell |
6,114
-495
| -7% | -$117K | 0.03% | 266 |
|
|
2020
Q3 | $1.8M | Sell |
6,609
-44
| -0.7% | -$12K | 0.04% | 220 |
|
|
2020
Q2 | $1.93M | Sell |
6,653
-648
| -9% | -$188K | 0.04% | 199 |
|
|
2020
Q1 | $1.74M | Sell |
7,301
-31
| -0.4% | -$7.38K | 0.04% | 203 |
|
|
2019
Q4 | $1.61M | Buy |
7,332
+143
| +2% | +$31.3K | 0.03% | 263 |
|
|
2019
Q3 | $1.22M | Buy |
7,189
+76
| +1% | +$12.9K | 0.02% | 311 |
|
|
2019
Q2 | $1.3M | Sell |
7,113
-60
| -0.8% | -$11K | 0.03% | 291 |
|
|
2019
Q1 | $1.32M | Buy |
7,173
+183
| +3% | +$33.7K | 0.03% | 288 |
|
|
2018
Q4 | $1.16M | Sell |
6,990
-303
| -4% | -$50.2K | 0.03% | 294 |
|
|
2018
Q3 | $1.41M | Buy |
7,293
+412
| +6% | +$79.4K | 0.03% | 278 |
|
|
2018
Q2 | $1.17M | Buy |
6,881
+455
| +7% | +$77.3K | 0.02% | 303 |
|
|
2018
Q1 | $1.05M | Buy |
6,426
+330
| +5% | +$53.8K | 0.02% | 321 |
|
|
2017
Q4 | $914K | Sell |
6,096
-280
| -4% | -$42K | 0.02% | 350 |
|
|
2017
Q3 | $969K | Buy |
6,376
+29
| +0.5% | +$4.41K | 0.02% | 349 |
|
|
2017
Q2 | $818K | Buy |
6,347
+1,858
| +41% | +$239K | 0.02% | 392 |
|
|
2017
Q1 | $491K | Buy |
4,489
+174
| +4% | +$19K | 0.01% | 492 |
|
|
2016
Q4 | $318K | Sell |
4,315
-2,444
| -36% | -$180K | 0.01% | 578 |
|
|
2016
Q3 | $589K | Buy |
6,759
+628
| +10% | +$54.7K | 0.01% | 428 |
|
|
2016
Q2 | $527K | Buy |
6,131
+2,112
| +53% | +$182K | 0.01% | 439 |
|
|
2016
Q1 | $319K | Sell |
4,019
-4,152
| -51% | -$330K | 0.01% | 553 |
|
|
2015
Q4 | $1.03M | Buy |
8,171
+143
| +2% | +$18K | 0.03% | 308 |
|
|
2015
Q3 | $836K | Buy |
8,028
+1,621
| +25% | +$169K | 0.02% | 329 |
|
|
2015
Q2 | $791K | Sell |
6,407
-1,428
| -18% | -$176K | 0.02% | 356 |
|
|
2015
Q1 | $924K | Buy |
7,835
+539
| +7% | +$63.6K | 0.02% | 427 |
|
|
2014
Q4 | $867K | Sell |
7,296
-288
| -4% | -$34.2K | 0.02% | 442 |
|
|
2014
Q3 | $852K | Sell |
7,584
-505
| -6% | -$56.7K | 0.02% | 445 |
|
|
2014
Q2 | $766K | Sell |
8,089
-128
| -2% | -$12.1K | 0.02% | 474 |
|
|
2014
Q1 | $581K | Sell |
8,217
-163
| -2% | -$11.5K | 0.01% | 538 |
|
|
2013
Q4 | $623K | Buy |
8,380
+1,040
| +14% | +$77.3K | 0.01% | 512 |
|
|
2013
Q3 | $557K | Buy |
7,340
+495
| +7% | +$37.6K | 0.01% | 538 |
|
|
2013
Q2 | $548K | Buy |
+6,845
| New | +$548K | 0.01% | 543 |
|